As Chief Operating & Commercial Officer, Thomas Bonnefont leads the eyonis Business Unit from R&D to commercial strategy and market access. Before joining Median, Thomas was Global Commercial Vice-President at Guerbet Group where he built and expanded the Interventional Oncology franchise with a tremendous growth in the US, Europe and Asia-Pacific. Previously, Thomas held sales & marketing management positions within renowned organizations such as MicroPort, GE Healthcare, Laboratoires Pierre Fabre and Johnson & Johnson.